Antibody to IL-1 beta, IL-1 beta binding molecule, its use and process for production, first DNA construct, expression vector and pharmaceutical composition
It is described an IL-1 beta binding molecule, an antibody to human IL-1 beta, especially a human antibody to human IL-1 beta, wherein the CDRs of the heavy and light chains have amino acid sequences as defined in description. The molecule is useful for use in the treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritides.It is described an IL-1 beta binding molecule, an antibody to human IL-1 beta, especially a human antibody to human IL-1 beta, wherein the CDRs of the heavy and light chains have amino acid sequences as defined in description. The molecule is useful for use in the treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritides.
